IFNA1 and neoplasm: In terms of anti-tumor activity, both CAR T-cells and IFN-CAR T-cells exhibited robust elimination of BxPC-3 cells in the first two rounds of stimulation while the cytolytic activity was extinguished in round three (Figure 3C).